Skip to content
Recall Observatory FDA recall evidence

Drug product

Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01

D-0341-2024

February 06, 2024

Class II

Product summary

Firm
Mallinckrodt Hospital Products Inc.
Event
Event 93945
Status
Ongoing
Classification
Class II
Quantity
421 vials involved in this recall (2,448 vials distributed)
Official record key
drug-enforcement:D-0341-2024

Official wording

Reason: cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Code information: Lot #: 22TRP01-F2, Exp 6/30/2024

Distribution pattern: USA nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviations